DK1856531T3 - Fremgangsmåde til diagnosticering af dissemineret sclerose - Google Patents

Fremgangsmåde til diagnosticering af dissemineret sclerose

Info

Publication number
DK1856531T3
DK1856531T3 DK06765559.7T DK06765559T DK1856531T3 DK 1856531 T3 DK1856531 T3 DK 1856531T3 DK 06765559 T DK06765559 T DK 06765559T DK 1856531 T3 DK1856531 T3 DK 1856531T3
Authority
DK
Denmark
Prior art keywords
procedure
disseminated sclerosis
diagnosing
diagnosing disseminated
sclerosis
Prior art date
Application number
DK06765559.7T
Other languages
English (en)
Inventor
Nir Dotan
Avinoam Dukler
Mikael Scwartz
Original Assignee
Glycominds Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycominds Ltd filed Critical Glycominds Ltd
Application granted granted Critical
Publication of DK1856531T3 publication Critical patent/DK1856531T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/24Immunology or allergic disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/285Demyelinating diseases; Multipel sclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Testing Of Engines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Heat Treatment Of Steel (AREA)
  • Sorption Type Refrigeration Machines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Control Of Electric Motors In General (AREA)
  • Steering Control In Accordance With Driving Conditions (AREA)
DK06765559.7T 2005-01-31 2006-01-31 Fremgangsmåde til diagnosticering af dissemineret sclerose DK1856531T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/047,124 US7572592B2 (en) 2005-01-31 2005-01-31 Method for diagnosing multiple sclerosis
PCT/IB2006/001656 WO2006117689A2 (en) 2005-01-31 2006-01-31 Method for diagnosing multiple sclerosis

Publications (1)

Publication Number Publication Date
DK1856531T3 true DK1856531T3 (da) 2011-04-18

Family

ID=36757039

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06765559.7T DK1856531T3 (da) 2005-01-31 2006-01-31 Fremgangsmåde til diagnosticering af dissemineret sclerose

Country Status (15)

Country Link
US (4) US7572592B2 (da)
EP (1) EP1856531B1 (da)
AT (1) ATE493656T1 (da)
AU (1) AU2006242939B2 (da)
CA (1) CA2595277A1 (da)
CY (1) CY1111839T1 (da)
DE (1) DE602006019206D1 (da)
DK (1) DK1856531T3 (da)
ES (1) ES2358606T3 (da)
IL (1) IL184905A (da)
NZ (1) NZ560978A (da)
PL (1) PL1856531T3 (da)
PT (1) PT1856531E (da)
SI (1) SI1856531T1 (da)
WO (1) WO2006117689A2 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1529216T3 (da) * 2002-08-02 2008-02-25 Glycominds Ltd Fremgangsmåde til diagnosticering af dissemineret sklerose
US7572592B2 (en) * 2005-01-31 2009-08-11 Glycominds Ltd Method for diagnosing multiple sclerosis
US8216791B2 (en) * 2005-01-31 2012-07-10 Glycominds Ltd. Method for diagnosing multiple sclerosis
US20100105085A1 (en) * 2006-08-29 2010-04-29 Nir Dotan Method of diagnosing and stratifying anti-phospholipid syndrome
MX340916B (es) 2008-01-18 2016-07-29 President And Fellows Of Harvard College * Metodos para detectar señales de identificacion de enfermedad o condiciones en fluidos corporales.
EP2353004B1 (en) 2008-11-12 2018-01-03 Yeda Research and Development Co. Ltd. Diagnosis of multiple sclerosis
US20100203569A1 (en) * 2009-02-12 2010-08-12 Glycominks LTD Method for Evaluating Risk in Multiple Sclerosis
WO2011031472A2 (en) * 2009-08-25 2011-03-17 The Johns Hopkins University Detection of auto-antibodies to specific glycans as diagnostic tests for autoimmune diseases
US20130203624A1 (en) 2010-07-23 2013-08-08 President And Fellows Of Harvard College Methods of Detecting Prenatal or Pregnancy-Related Diseases or Conditions
EP2596132A4 (en) 2010-07-23 2013-12-18 Harvard College METHOD FOR DETECTING SIGNS FOR ILLNESS OR SUFFERING IN BODY FLUIDS
TW201209171A (en) 2010-07-23 2012-03-01 Harvard College Methods of detecting diseases or conditions using phagocytic cells
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
JP2015522260A (ja) 2012-06-15 2015-08-06 ハリー スティリ, 疾患または状態を検出する方法
MX2014015434A (es) 2012-06-15 2015-07-14 Harry Stylli Metodos para detectar enfermedades o condiciones utilizando celulas enfermas en circulacion.
WO2014164362A1 (en) 2013-03-09 2014-10-09 Harry Stylli Methods of detecting prostate cancer
NZ771629A (en) 2013-03-09 2022-12-23 Harry Stylli Methods of detecting cancer
CA2933554A1 (en) 2013-12-12 2015-06-18 The Brigham And Women's Hospital, Inc. Treating neurodegenerative disease
US10626464B2 (en) 2014-09-11 2020-04-21 Cell Mdx, Llc Methods of detecting prostate cancer
US10495646B2 (en) 2015-01-30 2019-12-03 The Regents Of The University Of California N-acetyl glucosamine as a biomarker of MS disease course
US10538794B2 (en) 2016-11-29 2020-01-21 Emory University Oligosaccharide libraries and methods of production
EP3401682A1 (en) 2017-05-09 2018-11-14 Université de Nantes Diagnosis, prevention and treatment of demyelinating disorders of the central nervous system
WO2021158844A1 (en) * 2020-02-07 2021-08-12 Argentum Pharmaceuticals Llc Treatment and dosing regimen for s1p receptor modulator
US11135197B2 (en) 2020-02-07 2021-10-05 Argentum Pharmaceuticals Llc Dosage regimen of an S1P receptor modulator
WO2021158845A1 (en) * 2020-02-07 2021-08-12 Argentum Pharmaceuticals Llc Treatment and dosing regimen for s1p receptor modulator
WO2021158841A1 (en) * 2020-02-07 2021-08-12 Argentum Pharmaceuticals Llc Treatment and dosing regimen for s1p receptor modulator
WO2021158839A1 (en) * 2020-02-07 2021-08-12 Argentum Pharmaceuticals Llc Treatment and dosing regimen for s1p receptor modulator
WO2021158847A1 (en) * 2020-02-07 2021-08-12 Argentum Pharmaceuticals Llc Treatment and dosing regimen for s1p receptor modulator
WO2021158843A1 (en) * 2020-02-07 2021-08-12 Argentum Pharmaceuticals Llc Treatment and dosing regimen for s1p receptor modulator

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030560A (en) * 1988-11-04 1991-07-09 Immucor, Inc. Method for drying mammalian cells for use in solid phase immunoassays and articles incorporating same
AU776632B2 (en) 1999-02-17 2004-09-16 Glycominds Ltd. Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
US20010051349A1 (en) 2000-02-17 2001-12-13 Glycominds Ltd. Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
US6994966B2 (en) 2000-02-17 2006-02-07 Glycominds Ltd. Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
US6762032B1 (en) 1999-08-23 2004-07-13 Biocrystal, Ltd. Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response
KR20020089323A (ko) 2000-01-10 2002-11-29 제노스펙트라 인코포레이티드 선형 프로브 캐리어
WO2002018950A1 (en) 2000-08-28 2002-03-07 The Trustees Of Columbia University In The City Of New York Detection of anti-glycolipid antibodies by latex agglutination assay
ITFI20010114A1 (it) 2001-06-22 2002-12-22 Univ Firenze Glicopeptidi,loro preparazione e loro uso nella diagnosi o nel trattamento terapeutico della sclerosi multipla
DK1529216T3 (da) * 2002-08-02 2008-02-25 Glycominds Ltd Fremgangsmåde til diagnosticering af dissemineret sklerose
US20040241763A1 (en) * 2002-08-02 2004-12-02 Nir Dotan Method for diagnosing multiple sclerosis
WO2004034031A2 (en) 2002-10-11 2004-04-22 The Regents Of The University Of California A method for diagnosis and prognosis of multiple sclerosis
US7572592B2 (en) * 2005-01-31 2009-08-11 Glycominds Ltd Method for diagnosing multiple sclerosis

Also Published As

Publication number Publication date
AU2006242939B2 (en) 2012-04-19
ES2358606T3 (es) 2011-05-12
PL1856531T3 (pl) 2011-07-29
IL184905A (en) 2012-02-29
US20090291456A1 (en) 2009-11-26
EP1856531A2 (en) 2007-11-21
WO2006117689A3 (en) 2007-01-25
SI1856531T1 (sl) 2011-05-31
US7572592B2 (en) 2009-08-11
IL184905A0 (en) 2007-12-03
US20110092383A1 (en) 2011-04-21
CA2595277A1 (en) 2006-11-09
CY1111839T1 (el) 2015-10-07
NZ560978A (en) 2010-12-24
ATE493656T1 (de) 2011-01-15
US20060234301A1 (en) 2006-10-19
AU2006242939A1 (en) 2006-11-09
US8129128B2 (en) 2012-03-06
EP1856531B1 (en) 2010-12-29
US20060172338A1 (en) 2006-08-03
PT1856531E (pt) 2011-03-24
DE602006019206D1 (de) 2011-02-10
WO2006117689A2 (en) 2006-11-09
US7906291B2 (en) 2011-03-15

Similar Documents

Publication Publication Date Title
DK1856531T3 (da) Fremgangsmåde til diagnosticering af dissemineret sclerose
CY2023018I1 (el) Συνθεσεις αντισωματων anti-ctla-4
CY1121208T1 (el) Σκευασματα αντισωματος ναταλιζουμαμπης
CY1118343T1 (el) Αντισωματα συνδεσης twεακ
HUS1600037I1 (hu) Anti-IL-17 ellenanyagok
HN2006015949A (es) Anticuerpos de p-caderina
DE602005013539D1 (de) Polycycloolefinpolymerzusammensetzungen für halbleiteranwendungen
DE602006006093D1 (de) Perfluorelastomerzusammensetzungen für tieftemperaturanwendungen
DE602006015151D1 (de) Vorrichtung für Kompressionsanastomose
EP1866904A4 (en) Human machine interface system for automotive application
EP1853313A4 (en) HUMANIZED L243 ANTIBODIES
DK1964852T3 (da) Anti-ilt7-antistof
EP1733480A4 (en) PERIODIC CALIBRATION FOR COMMUNICATION CHANNELS BY REFERRING UNDESIRABLE VARIATIONS
EP1850351A4 (en) ADHESIVE FOR CONNECTING CIRCUITS
DE502005005946D1 (de) Flanschverbindung für Leitungen
EA200801884A1 (ru) Новый способ синтеза ранелата стронция и его гидратов
DK2171060T3 (da) Superagonistisk anti-CD28-antistof
EP1805515A4 (en) IMMUNODOSAGES FOR LAMOTRIGIN
DE602006006369D1 (de) Entwicklerzusammensetzungen
DK1761785T3 (da) Fremgangsmåde til diagnosticering af Lawsonia intracellularis
EP1877580A4 (en) IMMUNOLOGICAL PROTEINS OF LAWSONIA INTRACELLULARIS
DE602006005624D1 (de) Metaboliten für nk-i-antagonisten zur emesis
MX2007013108A (es) Reactivos que enlazan ccx-ckr2.
DE502006005950D1 (de) Signalleuchte, insbesondere für den Wetter ausgesetzten Aussenbereich
DE502006002170D1 (de) Übertragungselement für die Übertragung von Betätigungsbewegungen